Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
645
NCT00734253
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2008
Completion: Aug 31, 2010
NCT02156843
Pyridorin in Diabetic Nephropathy
Phase: Phase 3
Start: Jun 30, 2014
Completion: Mar 31, 2018